T-REGULATORY CELLS IN CROHN’S DISEASE PATIENTS TREATED WITH INFLIXIMAB

(1) Centre for Immunology and Infectious Disease, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, United Kingdom

(2) First Department of Medicine, S. Matteo Hospital, Pavia

(3) Immunotherapy and Gene Therapy Unit, Istituto Nazionale dei Tumori, Milan

(4) Research Center, Bambino Gesù Hospital, Rome

(5) Gastroenterology Division, L. Sacco University Hospital, Milan, Italy



This item was part of the IMMFLAMMATORY BOWEL DISEASE III session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A469